AMGN Amgen PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: AMGN
- PE Ratio
The current PE ratio for Amgen stock as of Jul 31, 2025 is 26.71. This is calculated based on the current EPS of $11.05 and the stock price of $295.1 per share. The P/E ratio has a decrease of 32% from the past four quarters average of 39.2.
AMGN PE ratio history
The average historical PE ratio of Amgen for the last ten years is 24.61. The current PE ratio of 26.71 is 9% above the historical average. Over the past ten years, AMGN's PE ratio was at its highest in the Dec 2017 quarter at 64.17, when the stock price was $173.9 and the EPS was $2.71. The lowest value was in the Dec 2016 quarter, when it reached 14.17 with a price of $146.21 and an EPS of $10.32.
Amgen PE ratio by year
Maximum annual increase: 352.86% in 2017
Maximum annual decrease: -76.11% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 34.2 | 49.15% | $260.64 | $7.62 |
| 2023 | 22.93 | 6.35% | $288.02 | $12.56 |
| 2022 | 21.56 | -0.92% | $262.64 | $12.18 |
| 2021 | 21.76 | 17.37% | $224.97 | $10.34 |
| 2020 | 18.54 | -0.32% | $229.92 | $12.4 |
| 2019 | 18.6 | 21.33% | $241.07 | $12.96 |
| 2018 | 15.33 | -76.11% | $194.67 | $12.7 |
| 2017 | 64.17 | 352.86% | $173.9 | $2.71 |
| 2016 | 14.17 | -20.12% | $146.21 | $10.32 |
| 2015 | 17.74 | -24.29% | $162.33 | $9.15 |
| 2014 | 23.43 | 38.64% | $159.29 | $6.8 |
| 2013 | 16.9 | 9.95% | $114.08 | $6.75 |
| 2012 | 15.37 | -2.6% | $86.2 | $5.61 |
| 2011 | 15.78 | 38.54% | $64.21 | $4.07 |
| 2010 | 11.39 | -8.81% | $54.9 | $4.82 |
Amgen PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 28.19 | -17.57% | $311.55 | $11.05 |
| Dec 2024 | 34.2 | -16.26% | $260.64 | $7.62 |
| Sep 2024 | 40.84 | -23.53% | $322.21 | $7.89 |
| Jun 2024 | 53.41 | 32.24% | $312.45 | $5.85 |
| Mar 2024 | 40.39 | 76.14% | $284.32 | $7.04 |
| Dec 2023 | 22.93 | 20.75% | $288.02 | $12.56 |
| Sep 2023 | 18.99 | 27.71% | $268.76 | $14.15 |
| Jun 2023 | 14.87 | -8.88% | $222.02 | $14.93 |
| Mar 2023 | 16.32 | -24.3% | $241.75 | $14.81 |
| Dec 2022 | 21.56 | 19.78% | $262.64 | $12.18 |
| Sep 2022 | 18 | -12.49% | $225.4 | $12.52 |
| Jun 2022 | 20.57 | -13.39% | $243.3 | $11.83 |
| Mar 2022 | 23.75 | 9.15% | $241.82 | $10.18 |
| Dec 2021 | 21.76 | -0.05% | $224.97 | $10.34 |
| Sep 2021 | 21.77 | -11.58% | $212.65 | $9.77 |
AMGN Price vs fair value
AMGN average PE ratio chart
AMGN's current P/E ratio is above the 5 and 10-year historical averages, but it is below the 3-year average.
AMGN PE vs peers
AMGN's PE ratio is lower than its peer stocks LLY and ABBV, but it is greater than JNJ's and ABT's. Amgen is presently trading at a lower PE ratio (26.71) than its peer group average of 30.37.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 12.19 | $18.73B |
| ABT Abbott Laboratories | 15.92 | $221.68B |
| PFE Pfizer Inc | 16.8 | $132.75B |
| BMY Bristol Myers Squibb Co | 17.65 | $89.45B |
| JNJ Johnson & Johnson | 17.69 | $400.84B |
| GILD Gilead Sciences Inc | 23.7 | $140.65B |
| AMGN Amgen Inc | 26.81 | $159.31B |
| LLY ELI LILLY & Co | 61.47 | $718.95B |
| ABBV AbbVie Inc | 82.6 | $344.34B |
| ILMN Illumina Inc | N/A | $15.41B |
Frequently asked questions
What is Amgen's PE ratio?
AMGN's price to earnings ratio is 26.71 as of Jul 31, 2025.
What is the 3-year average PE ratio for Amgen (AMGN)?
Over the last 3 years, the average price to earnings ratio for AMGN stock is 28.15.
What is the 5-year average PE ratio for Amgen (AMGN)?
Over the last 5 years, the average price to earnings ratio for AMGN stock is 25.34.
What is the highest PE ratio for AMGN?
In the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 64.17.
How does the current PE ratio for AMGN compare to its historical average?
The current price to earnings ratio of AMGN is 9% higher than the 10-year historical average.
How is AMGN's PE ratio calculated (Amgen PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jul 31, 2025), Amgen's stock price is $295.1. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $11.05. Therefore, Amgen's P/E ratio for today is 26.71. PE RATIO(26.71) = STOCK PRICE($295.1) / TTM EPS($11.05)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.